semaglutide and alcohol use disorder GLP-1 reduces heavy drinking days in treatment seeking people with obesity, finds small trial Wegovy and Ozempic (semaglutide) are

Association between type I interferon pathway activation and clinical outcomes in rheumatic and musculoskeletal diseases: a systematic literature review informing EULAR points to consider

This can help you understand why your appetite may be minimal on certain days and higher on others, as you approach your next dose

Long-term major adverse liver outcomes in 1,260 patients with non-cirrhotic NAFLD

Estos medicamentos ralentizan la digestin y envan una seal al cerebro para dejar de comer, lo cual, en consecuencia, hace que se baje de peso

Follow these simple steps to begin your personalized health journey

Some risks include: Loss of Muscle Mass: If you lose weight too fast, your heart muscle can weaken, leading to irregular heartbeats